These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8209340)

  • 1. [Insulin pumps and drop in pressure].
    Aanderud L; Hansen EM
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):570-2. PubMed ID: 8209340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unintended Insulin Pump Delivery in Hyperbaric Conditions.
    Bertuzzi F; Pintaudi B; Bonomo M; Garuti F
    Diabetes Technol Ther; 2017 Apr; 19(4):265-268. PubMed ID: 28231029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of insulin lispro in insulin infusion systems.
    Lougheed WD; Zinman B; Strack TR; Janis LJ; Weymouth AB; Bernstein EA; Korbas AM; Frank BH
    Diabetes Care; 1997 Jul; 20(7):1061-5. PubMed ID: 9203437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pumps and glucose regulation.
    Thompson JS; Duckworth WC
    World J Surg; 2001 Apr; 25(4):523-6. PubMed ID: 11344407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events.
    Cope JU; Morrison AE; Samuels-Reid J
    Pediatrics; 2008 May; 121(5):e1133-8. PubMed ID: 18450857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in altitude cause unintended insulin delivery from insulin pumps: mechanisms and implications.
    King BR; Goss PW; Paterson MA; Crock PA; Anderson DG
    Diabetes Care; 2011 Sep; 34(9):1932-3. PubMed ID: 21816978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled insulin--does it become reality?
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elastomeric pump reliability in postoperative regional anesthesia: a survey of 430 consecutive devices.
    Remerand F; Vuitton AS; Palud M; Buchet S; Pourrat X; Baud A; Laffon M; Fusciardi J
    Anesth Analg; 2008 Dec; 107(6):2079-84. PubMed ID: 19020162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions.
    Zisser H
    Diabetes Care; 2008 Feb; 31(2):238-9. PubMed ID: 18056889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M; Ruxer J; Loba J
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillary fragility during air exposure of man to 1-5 ATA and after decompression.
    Halbreich U; Torbati D
    Aviat Space Environ Med; 1978 Nov; 49(11):1295-6. PubMed ID: 718572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine studies during a 14-day continuous exposure to 5.2 per cent O 2 in N 2 at pressure equivalent to 100 FSW (4 ATA).
    Leach CS; Alexander WC; Fischer CL; Lambertsen CJ; Johnson PC
    Aerosp Med; 1973 Jul; 44(7):855-9. PubMed ID: 4352047
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventilatory effects of prolonged hyperoxia at pressures of 1.5-3.0 ATA.
    Gelfand R; Lambertsen CJ; Clark JM
    Aviat Space Environ Med; 2006 Aug; 77(8):801-10. PubMed ID: 16909873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin infusion induces endothelin-1-dependent hypertension in rats.
    Juan CC; Shen YW; Chien Y; Lin YJ; Chang SF; Ho LT
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E948-54. PubMed ID: 15226099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable insulin pumps. A position statement about their clinical use.
    Renard E; Schaepelynck-Bélicar P;
    Diabetes Metab; 2007 Apr; 33(2):158-66. PubMed ID: 17300973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.